Powered by Hamilton Lane. Learn more about the private markets.

AeroSafe Global is a premier leader in the pharmaceutical cold chain industry, enabling its biopharma partners to safely deliver their life-saving therapies to healthcare providers and patients with its end-to-end sustainable solutions.

With a unique business model built on reusable shippers and unmatched reverse logistics services, AeroSafe provides biopharma partners with hassle-free sustainable solutions to safely deliver their temperature-sensitive products, significantly reducing the amount of landfill waste. 

INDUSTRY

Materials

Energy & Environment

IMPACT SECTOR

AeroSafe's Impact

Alignment of Social and Business Mission 
  • AeroSafe’s mission is to improve patient lives by ensuring the safe, sustainable delivery and effective use of biopharma therapeutics. The company is committed to tackling the most pressing challenges in the global pharma supply chain industry by driving growth through innovation and customer dedication.

Impact metrics tracked1 

1Metrics shown represent 2022 CY annual figures. Metrics calculated and provided directly by the general partner or underlying company.

metric tons of CO2 reduced

22,000

1M+  

Shipments with 98% re-use return rate

Shipments, of COVID-19 vaccine, containing up to 928M doses

279K+

metric tons of reduced landfill waste 

10K

Data provided directly by the general partner or underlying company.

  • As of November 2022, more than 50 world-class healthcare organizations, including 12 of the top 20 global pharmaceutical manufacturers, rely on AeroSafe for its comprehensive cold chain-as-a-service offering.  

  • The company supports pharmaceutical distribution in 95 countries across eight global centers. As a result of its container reuse program, AeroSafe has already reduced its customer’s carbon footprint by 70% and landfill waste by 95%. 

Health & Wellness

  • AeroSafe’s mission is to improve patient lives by ensuring the safe, sustainable delivery and effective use of biopharma therapeutics. The company is committed to tackling the most pressing challenges in the global pharma supply chain industry by driving growth through innovation and customer dedication.

Health & Wellness

Powered by Hamilton Lane.
Learn more about the private markets.

Impact metrics tracked1 

metric tons of CO2 reduced

22,000

1M+  

Shipments with 98% re-use return rate

metric tons of reduced landfill waste 

10K

1Metrics shown represent 2022 CY annual figures. Metrics calculated and provided directly by the general partner or underlying company.

Shipments, of COVID-19 vaccine, containing up to 928M doses

279K+

Alignment of Social and Business Mission 
  • As of November 2022, more than 50 world-class healthcare organizations, including 12 of the top 20 global pharmaceutical manufacturers, rely on AeroSafe for its comprehensive cold chain-as-a-service offering.  

  • The company supports pharmaceutical distribution in 95 countries across eight global centers. As a result of its container reuse program, AeroSafe has already reduced its customer’s carbon footprint by 70% and landfill waste by 95%. 

AeroSafe's Impact

Energy & Environment

IMPACT SECTOR

INDUSTRY

Materials

With a unique business model built on reusable shippers and unmatched reverse logistics services, AeroSafe provides biopharma partners with hassle-free sustainable solutions to safely deliver their temperature-sensitive products, significantly reducing the amount of landfill waste. 

AeroSafe Global is a premier leader in the pharmaceutical cold chain industry, enabling its biopharma partners to safely deliver their life-saving therapies to healthcare providers and patients with its end-to-end sustainable solutions.

AeroSafe